Skip to content

Supermicrosurgery for Breast Cancer Survivors With Lymphedema.

Supermicrosurgery for Breast Cancer Survivors With Lymphedema. -Prospective Randomized Clinical and Patient-reported Outcomes.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03578380
Enrollment
100
Registered
2018-07-06
Start date
2016-01-26
Completion date
2024-12-31
Last updated
2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Secondary Lymphedema

Keywords

Lymphovenous bypass, Lymphovenous anastomosis, Supermicrosurgery, Lymphangiography, MD Anderson Lymphedema Stage

Brief summary

A randomised prospective investigation of volume and quality of life results with lymphovenous anastomosis in patients with unilateral arm lymphedema after breast cancer using Indocyanine Green lymphangiography and MD Anderson Staging.

Detailed description

This is a randomized study comparing lymphovenous anastomosis versus conservative (compression) treatment for lymphoedema after breast cancer surgery - 50 patients to be included in each study arm. The primary endpoint is volume change measured by submersion and changes in arm circumference at defined levels from the wrist. Secondary endpoint is health related quality of life measured by questionnaire Short Form 36 (SF-36), Hospital Anxiety Depression Score (HADS), Fatigue Questionnaire (FQ) and a disease-specific questionnaire, Upper Limb Lymphedema score (ULL27).

Interventions

PROCEDURESurgery

Lymphovenous anastomosis

OTHERCompression and drainage therapy

Treatment with compression stockings and manual drainage (massage therapy)

Sponsors

University of Oslo
CollaboratorOTHER
Ohio State University
CollaboratorOTHER
Sykehuset Telemark
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Unilateral lymphedema of the arm secondary to breast cancer treatment. Stage 1-3 operable lymphedema.

Exclusion criteria

* Frequent or severe cellulitis. All other lymphedema.

Design outcomes

Primary

MeasureTime frameDescription
Volume12 monthsVolume of arm as described by submersion and circumference measures

Secondary

MeasureTime frameDescription
Health related quality of life ULL2712 monthsTo be measured by questionnaire Upper Limb Lymphedema score 27 (ULL27) by Professor Robert Launois at REES France. The scale measures health related quality of life in patients with upper limb lymphedema. Construction: 27 questions rated from 1 (lowest quality of life) to 5 highest quality of life. Dimensions: There are 3 dimensions assessing symptoms, self value, everyday social life. Total score 27-135 Symptom score: 18-90 Self value: 5-25 Social life: 4-20 Question 20 and 22 are part of the self value dimension and are control questions with reverse scores, i.e 1 represents highest quality of life and 5 represents lowest quality of life. The scores for question 20 and 22 are later reversed when adding the total score.

Countries

Norway

Contacts

Primary ContactLars Johan Sandberg, MD
johansandberg@hotmail.com+4735003456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026